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pen accessAbstract The aqueous and alcoholic extracts of the fresh aerial parts of Lippia citriodora Kunth,
family Verbenaceae, cultivated in Egypt, exhibited variable antiinﬂammatory, antipyretic, analgesic
and antioxidant properties. Three phenolic compounds; two phenolic acids, dihydrocaffeic acid (1)
and 4-hydroxycinnamic acid (3) and a ﬂavonoid glycoside, luteolin-7-O-glucoside (2), were isolated
and identiﬁed from the ethyl acetate fraction of the plant. The structures of the isolated compounds
were elucidated on the basis of spectral analysis. The effects of explant type, method of sterilization
and growth regulators on the in-vitro callus formation of L. citriodora were studied. Shoot tips and
leaf explants (cut in the midrib region) sterilized by soaking in 0.2% mercuric chloride for 5 min,
then washed twice with sterilized distilled water gave callus, on Murashige and Skoog (MS) medium
impregnated with 4 mg/L 6-benzyl amino purine (BAP). Spectrophotometric estimation of the total
ﬂavonoids showed that the fresh in-vitro formed callus contained 68.4% of the total ﬂavonoids of
the fresh aerial parts of the conventional plant.
ª 2012 Faculty of Pharmacy, Cairo University. Production and hosting by Elsevier B.V.
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Lemon verbena, Lippia citriodora Kunth, [syn. Lippia triphylla
(L’Her.) Kuntze; Aloysia triphylla (L’Her.) Britton] was culti-
vated in Egypt for its lemon-like aroma to be used in herbal
tea preparations, as it is known for its antispasmodic, antipy-
retic, sedative and digestive properties.1–4
Phenolic compounds (mainly ﬂavonoids, phenolic acids and
phenylpropanoids) were reported to be responsible for most of
the pharmacological activities of lemon verbena,2,3,5 such as
analgesic, antiinﬂammatory and antioxidant effects.6,7 In spite
of attributing many of the activities of lemon verbena to its
main component, the phenyl propanoid verbascoside, we can-
not assume that all the bioactivities of the plant extract are
2 S.S. El-Hawary et al.due to just one compound since several researches have shown
interactions between phenolic compounds, mainly synergistic
and antagonistic effects.5 Flavonoids and other phenolic com-
pounds were isolated from L. citriodora obtained from different
localities.8,9 However, hardly any datum was available concern-
ing L. citriodora cultivated in Egypt except for the study of the
essential oil and its bioactivities.10
Although L. citriodora can be cultivated in any soil yet it
cannot withstand salty ones. The seed being minute, the plant
propagation is mainly by cuttings in late spring.11 Foliation is
in spring and summer and the plant loses its leaves and shrivels
at the end of winter looking really dead.12 Research articles
concerning the micropropagation of Lippia were conﬁned to
species other than L. citriodora.13,14 Trials of in-vitro propaga-
tion deemed, therefore, necessary as a ﬁrst step for an Egyptian
cultivar with a high content of active ingredients.
The present study aimed to evaluate the medicinal potential-
ity of the alcoholic and aqueous extracts of L. citriodoraKunth,
cultivated in Egypt, as well as, to investigate the phenolic com-
position of the most active extract. This report stressed also on
establishment of suitable conditions for the in-vitro callus for-
mation of the cited plant.2. Materials and methods
2.1. Plant material
Samples of aerial parts of L. citriodora were obtained from
plants cultivated in a private farm in Mounuﬁa, Egypt. Identi-
ﬁcation of the plant was conﬁrmed by Professor Dr. Abd El-
Salam Al-Nowaihi, Professor of Plant Taxonomy, Faculty of
Science, Ain Shams University. Voucher specimens are depos-
ited at the herbarium of the Pharmacognosy Department, Fac-
ulty of Pharmacy, Cairo University.2.2. Biological screening
2.2.1. Experimental animals
Male albino mice (25–30 g) were used for the acute toxicity
testing, and adult male albino rats (130–150 g) for studying
the analgesic, antipyretic, anti-inﬂammatory and antioxidant
activities. Animals were obtained from the animal-breeding
unit of National Research Center, El-Dokki, Giza, Egypt.
They were fed on a standard laboratory diet under hygienic
conditions and water supplied ad libitum.Table 1 Acute antiinﬂammatory activity of the alcoholic and aqueo
(n= 6).
Group Dose (mg/kg b.wt)
Control 1 ml saline
Alcoholic extract 50
Aqueous extract 50
Indomethacin 20
a Calculated as regard to the control group; b.wt, body weight.
* P< 0.01 vs. control group.2.2.2. Tested extracts
The aqueous and alcoholic extracts were prepared by boiling
the aerial parts (65 and 110 g) in distilled water and macerating
them in successive portions of 70% ethanol till exhaustion,
respectively. The extracts were separately evaporated till dry-
ness and the residues (8 and 14.5 g, respectively) were redis-
solved in distilled water (containing few drops of Tween 80
in the case of the alcoholic extract) to give solutions of 25%
(w/v) concentration.
2.2.3. Acute toxicity
LD50 of both aqueous and alcoholic extracts of L. citriodora
was estimated according to the procedure developed by Kar-
ber, 1931.15
2.2.4. Pharmacological experiments
Animals were divided into four groups, each of six. The ﬁrst
group was considered as a control, the second was given or-
ally the appropriate standard drug while the other two
groups each received 100 mg/kg b.wt. of the test extracts.
The anti-inﬂammatory activity was determined according to
the method described by Winter et al.16 Carrageenan,
0.1 ml of 1% solution, (Sigma-Aldrich, MO, USA) was used
to induce inﬂammation and 20 mg/kg b.wt. indomethacin
(Epico Pharmaceutical Co., Egypt) was used as a standard
anti-inﬂammatory drug. The analgesic activity was evaluated
according to Charlier et al.17 using dipyrone-metamizole,
50 mg/kg b.wt., (Novalgin, Hoechst Orient, Cairo, Egypt) as
a standard analgesic. The antipyretic effect was tested follow-
ing the method of Bush and Alexander.18 Brewers’ dry yeast,
1 ml/100 g b.wt. of 40% suspension, (Rehab Food Company,
Cairo, Egypt) was given by intramuscular injection to induce
hyperthermia and 20 mg/kg b.wt. paracetamol (Paramol,
Misr Pharmaceutical Co., Mataria, Egypt) was the standard
antipyretic.
For evaluation of the antioxidant activity, animals were
divided into ﬁve groups, each of 10. Four of the groups were
treated as for the previously mentioned bioactivity tests,
where as the ﬁfth group was given Alloxan I. P., 150 mg/
kg b.wt. (Sigma-Aldrich, MO, USA) to induce diabetes melli-
tus. The antioxidant activity was estimated by determining
the blood glutathione level of the diabetic rats19 as compared
to dl a- tocopheryl acetate as a positive control (Vitamin E,
Pharco Pharmaceutical Co., Egypt). All data were expressed
as mean ± SE and the statistical signiﬁcance was evaluated
by Student’s t test.20us extracts of L. citriodora and indomethacin in male albino rats
% edema
Mean ± SE % of changea
61.7 ± 1.9 –
26.2 ± 0.5* 57.536
29.3 ± 0.8* 52.512
21.4 ± 0.6* 65.316
Table 2 Analgesic activity of alcoholic and aqueous extracts of L. citriodora and novalgin in male albino rat (n= 6).
Group Dose (mg/kg b.wt) Volts needed after single oral dose
Volts needed before treatment(zero time) 1 h 2 h
Mean ± SE % of changea Mean ± SE % of changea
Control 1 ml saline 74.3 ± 1.4 75.1 ± 1.6 1.077 74.8 ± 2.1 0.673
Alcoholic extract 50 76.2 ± 1.5 126.2 ± 4.3* 65.617 143.2 ± 5.7
*
87. 927
Aqueous extract 50 79.3 ± 1.4 112.6 ± 3.7* 41.992 131.8 ± 5.2
*
66.204
Novalgin 50 78.2 ± 1.2 151.6 ± 5.8* 93.862 172.4 ± 6.3
*
120.460
a Calculated as regard to the control group; b.wt, body weight.
* P< 0.01 vs. control group.
Table 3 Antipyretic activity of the alcoholic and aqueous extracts of L. citriodora and paracetamol in male albino rats (n= 6).
Group Dose (mg/kg b.wt) Body temperature change
Induced rise in temperature 1 h 2 h
Mean ± SE % of changea Mean ± SE % of changea
Control 1 ml saline 38.7 ± 0.2 39.1 ± 0.2 1.034 39.2 ± 0.3 1.292
Alcoholic extract 50 39.4 ± 0.3 38.1 ± 0.3* 3.299 37.2 ± 0.1* 5.584
Aqueous extract 50 39.8 ± 0.4 38.3 ± 0.4* 3.769 37.1 ± 0.2* 6.784
Paracetamol 20 39.2 ± 0.3 37.8 ± 0.1* 3.571 36.8 ± 0.1* 6.122
a Calculated as regard to the control group; b.wt, body weight.
* P< 0.01 vs. control group.
Table 4 Antioxidant activity of the alcoholic and aqueous extracts of L. citriodora and vitamin E (n= 10).
Group Blood glutathione (mg%) % of changea
Control 36.2 ± 1.3 –
Diabetic 22.3 ± 0.9* 38.398
Diabetic + alcoholic extract(50 mg/kg b.wt) 35.2 ± 1.4 2.762
Diabetic + aqueous extract(50 mg/kg b.wt) 34.7 ± 0.8 4.144
Diabetic + vitamin E(75 mg/kg) 35.8 ± 1.1 1.105
a Calculated as regard to the control group.
* P< 0.01 vs. control group.
Table 5 Spectral data of compounds 2 and 3 isolated from L. citriodora.
Compounds UV 1H NMR (300 MHz, DMSO-d6)
13C NMR (75 MHz, DMSO-d6)
2 kmax (MeOH): 250, 291.4sh, 335;
(MeOH+NaOMe) 263, 299.6sh, 380;
(MeOH+AlCl3) 264.2, 300sh, 374, 466;
(MeOH+AlCl3/HCl) 262, 278sh, 329, 414;
(MeOH+NaOAc) 255, 289sh, 342, 388sh;
(MeOH+NaOAc/H3BO4)
257, 295.4sh, 359
d 6.65 (1H, S, H-3);
6.48(1H, d, J= 2.7 Hz, H-6);
6.76 (1H, d, J= 2.7 Hz, H-8);
7.05 (1H, S, H-50); 7.44 (1H, S, H-20);
7.49 (1H, S, H-60); the sugar moiety: d 5.12
(1H, d, J= 8.1 HZ, H-100); 3.4–3.5
(overlapped peaks, H-300 and H-400); 3.6
(1H, m, H-500); 3.65 (1H, m, H600a); 3.84
(1H, m, H600b)
166.35 (C-2), 102.75 (C-3), 182
(C-4), 161.33 (C-5), 101.65 (C-6),
163.5 (C-7), 94.67 (C-8), 157 (C-
9), 109.8 (C-10), 120.14 (C-10),
113.96 (C-20), 145.33 (C-30), 149
(C-40), 116.34(C-50), 116.8 (C-60),
100.67(C-100), 72.8 (C-200), 75 (C-
300), 70.75 (C-400), 79.86 (C-500),
61.14 (C-600)
3 kmax (MeOH): 283 and 323 nm d 8.5(1H, S, H-1); 6.7
(2H, d, J= 2.6 Hz, H2 and
H-6); 7.74 (2H, d, J= 2.7 Hz, H-3
and H-5); 7.5 (1 H d, J= 14 Hz, H-7);
6.2 (1H, d, J= 14 Hz, H-8); 9.1 (1H, S, H-9)
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4 S.S. El-Hawary et al.2.3. Isolation of phenolics
The air-dried aerial parts (1 kg) of L. citriodora were extracted
with successive portions of 70%ethanol till exhaustion. The eth-
anolic extract was collected and concentrated under reduced
pressure to give a viscous residue (130 g). This residue was sus-
pended in the least amount of distilled water and partitioned
successively with petroleum ether, chloroform and ethyl acetate.
The ethyl acetate fraction (6.66 g) was chromatographed on a
vacuum liquid chromatography column (VLC) (92 g,
5 · 14 cm, silica gel G, E-Merck). Elution was carried out by
gradiently increasing the polarity using chloroform, ethyl ace-
tate and methanol. The collected fractions (39 fractions,
100 ml each) weremonitored byTLC (silica gelGF254 precoated
plates, Fluka,Germany) underUV light (at 254 and 366 nm) be-
fore and after exposure to ammonia vapor. Spraying with AlCl3
or p-anisaldehyde-sulfuric acid spray reagent, followed by heat-
ing at 110 C, was also carried out. Solvent system used was
chloroform: methanol: formic acid, 8:2:0.5. Fractions were
pooled to give four major collective fractions (1–4). Fraction 2
(2 g) was rechromatographed on a Sephadex LH-20 column
(1 · 20 cm, Pharmacia Fine Chemicals AB Uppsala, Sweden)
using methanol as an eluent to give compound 1 (5 mg) and
compound 2 (25 mg). Fraction 3 (1.2 g) was puriﬁed on succes-
sive Sephadex LH-20 columns (1 · 16 cm) using methanol:
water (50:50) to give compound 3 (10 mg). Mass spectra of the
compounds were measured using Shimadzu QP-2010 Plus,
70 eV. 1HNMR (300 MHz) and 13CNMR (75 MHz) weremea-
sured on a Varian Mercury-VX-300 NMR instrument. The
NMR spectra were recorded in DMSO-d6, and chemical shifts
were given in d (ppm) relative to TMS as an internal standard.
All solvents used were of analytical grade.2.4. In-vitro propagation
The fresh aerial parts of L. citriodora were washed with soapy
water, rinsed several times with running tap water, and di-
vided into three groups for sterilization: group (1), was trea-
ted with acetone (2 min) (Adwic, Cairo, Egypt) followed by
Chlorex 30% (1.5% sodium hypochlorite) for 5 min, HgCl2
0.2% (5 min) (Universal Fine Chemical Pvt. Ltd.), then
rinsed twice with sterilized distilled water; group (2), was
treated with acetone (2 min) followed by HgCl2 0.2%
(5 min), then rinsed twice with sterilized distilled water; group
(3), was treated with HgCl2 0.2% (5 min), then rinsed twice
with sterilized distilled water.
The sterilized aerial parts were aseptically excised to give
four types of explants: shoot tips, nodes and internodes
(0.5–1 cm each), and leaves cut into 1 cm square pieces (some
cut in the midrib region and others in the lamina region).
Murashige and Skoog (MS) medium, in full strength, was
used as a basal culture medium.21 The media were enriched
with different concentrations of 6-benzyl amino purine
(BAP) (Oxford) as an auxin, and different concentrations of
1-naphthaleneacetic acid (NAA) (Sigma) and/or indole-3-bu-
tyric acid (IBA) (Sigma) as cytokinins.2.5. Spectrophotometric estimation of total ﬂavonoids
The percentage of total ﬂavonoids was calculated as luteolin
adopting a colorimetric method modiﬁed after Abou Zid and
Figure 1 Sterilization groups for the in-vitro propagation of L.
citriodora explants and the corresponding percent of
Bioactivities, phenolic compounds and in-vitro propagation of Lippia citriodora Kunth cultivated in Egypt 5Elsherbeiny.22 A solution of 0.1 M aluminium chloride was
prepared according to US Pharmacopoeia, 2004.23 A standard
calibration curve for luteolin was established. One gram of
each of the fresh aerial parts and callus of L. citriodora was
defatted with petroleum ether, then extracted with 95% etha-
nol to be used for the assay.
3. Results and discussion
The LD50 of the aqueous and alcoholic extracts were 6.4 g/
kg b.wt. and 5.9 g/kg b.wt., respectively, thus suggesting that
both could be considered as safe. Simon et al.24 stated that
L. citriodora Kunth is listed in USA as generally recognized
as safe (GRAS) for human consumption in the form of alco-
holic beverages and herbal teas.
contamination.3.1. Biological activities and isolation of active constituents
Both extracts possessed variable antiinﬂammatory, analgesic,
antipyretic and antioxidant activities. The alcoholic extract
showed higher antiinﬂammatory, analgesic and antioxidant
activities (Tables 1, 2 and 4, respectively), while the aqueous ex-
tract possessed a higher antipyretic activity (Table 3). The per-
cent of change in edema for the alcoholic extract was 57.5%
reaching nearly 88% that of Indomethacin which caused a
change of 65.3% (Table 1). The antiinﬂammatory activity of
Lippia alba was previously reported and attributed to the pres-
ence of theviridoside, an iridoid glucoside.25 Iridoids are com-
mon constituents in family Verbenaceae26 and their occurence
in lemon verbena was mentioned by Bilia et al.27 As reported
by Nakamura et al.,6 the analgesic activity of L. citriodora
may be due to the presence of verbascoside (acteoside) a phenyl-
ethanoid glycoside which was previously separated from the
Peruvian plant. Concerning the antipyretic activity, the aqueous
extract exerted an effect slightly exceeding that of paracetamol
(Table 3). As a matter of fact, L. citriodora is traditionally
known to be a good herb for fever.28 The high antioxidant activ-
ity observed for the alcoholic extract compared to vitamin E
(Table 4) could be attributed to its content of phenolic
compounds.29,30
These ﬁndings stimulated the authors to investigate the
phenolic composition of the alcoholic extract and especially
its ethyl acetate fraction. The three major phenolic com-
pounds, as detected by TLC, were isolated by repeated column
chromatography.
Compound 1 (5 mg) was obtained as yellow crystals, solu-
ble in methanol, ethanol and insoluble in petroleum ether
and n-hexane (Rf value 0.93). UV spectra revealed one absorp-
tion band at 286 nm similar to authentic dihydrocaffeic acid.31
Mass spectra showed 182 (M+)32 and base peak at 55 m/z.
Compound 1 was identiﬁed as dihydrocaffeic acid. To the best
of our knowledge, this is the ﬁrst report on the isolation of
dihydrocaffeic acid from L. citriodora.
Compound 2 (25 mg) was obtained as yellow amorphous
powder. By comparing its spectral data (Table 5) to those re-
ported for luteolin-7-O-glucoside,33–35 it was concluded that
compound 2 is luteolin-7-O-glucoside, previously isolated from
L. citriodora.9,27
Compound 3 (10 mg) was obtained as yellowish brown crys-
tals. Mass spectrum showed the molecular ion (M+) at164 m/z
and the base peak at 92 m/z (quinonium ion). Comparing itsspectral data (Table 5) to those of 4-hydroxycinnamic acid,36,37
it was concluded that compound 3 is 4-hydroxycinnamic acid.
This compound was previously isolated from Lippia scaberr-
ima.38 In fact such phenol carboxylic acids are precursors to
more complex secondary metabolites as ﬂavonoids.39 Collec-
tively, compounds 1 and 3 were isolated for the ﬁrst time from
L. citriodora.
3.2. In-vitro propagation and spectrophotometric estimation of
total ﬂavonoids
The effects of explant type, method of sterilization and growth
regulators on the in-vitro callus formation of L. citriodora were
studied (Table 6). Although the ﬁrst sterilization method, group
(1), gave the least percentage of contamination (Fig. 1), it hin-
dered callus formation probably being too vigorous to the ex-
plants’ tissues. So group (3) sterilization method was the best
as it allowed callus formation, in spite of leading to the highest
contamination percentage. Both shoot tips and leaf explants
(cut at the midrib) gave callus on MS media impregnated with
4 mg/L BAP. Neither using higher concentrations of BAP nor
addition of NAA and/or IBA did promote callus formation in
this study (Table 6). Ahmed et al.13 reported the induction of
shoots from nodal explants of Lippia nodiﬂora on MS medium
supplemented with 2.5 mg/L BAP and 0.5 mg/L kinetin. Also
Gupta et al.14 produced multiple shoots from stem nodal seg-
ments of L. alba on MS medium impregnated with 2 lg/ml 6-
benzyl adenine. The percent of total ﬂavonoids in the fresh cal-
lus was 0.78% calculated as luteolin compared to 1.14% in the
fresh aerial parts of the cultivated plant. However, further stud-
ies are still required to increase the ﬂavonoidal content of the
callus.
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